Conivaptan, a selective arginine vasopressin V1a and V2 receptor antagonist attenuates global cerebral edema following experimental cardiac arrest via perivascular pool of aquaporin-4 - Nakayama, S; Amiry-Moghaddam, M; Ottersen, O P; Bhardwaj, A (Neurocrit Care, 2016)